LISA PARROTT: Open Payments
NPI 1932982055 · HUNTSVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$668 in 36 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $615 · 2025 $668
Food & beverage: $668
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $88 |
| Lilly USA, LLC | 5 | $83 |
| Novo Nordisk Inc | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Exact Sciences Corporation | 4 | $61 |
| TOLMAR, INC. | 3 | $59 |
| Dexcom, Inc. | 3 | $49 |
| Astellas Pharma US Inc | 2 | $45 |
| PFIZER INC. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: GEMTESA, JATENZO, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit, Veozah, Ozempic, MOUNJARO, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
